Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.

Circulation research·2026
Same author

The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells.

The Journal of clinical investigation·2026
Same author

Alveolar type 2 cell LRP1 is needed for surfactant phospholipid metabolism and pulmonary function in mice.

Journal of lipid research·2026
Same author

Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial.

Nature medicine·2026
Same author

A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes.

Circulation research·2026
Same author

Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

Nature communications·2026

Related Experiment Video

Updated: Jun 17, 2026

Slicing and Culturing Pig Hearts under Physiological Conditions
07:54

Slicing and Culturing Pig Hearts under Physiological Conditions

Published on: March 20, 2020

Creating and curing fatty hearts.

Raffay S Khan1, Konstaninos Drosatos, Ira J Goldberg

  • 1Department of Medicine, Division of Preventive Medicine and Nutrition, Columbia University College of Physicians & Surgeons, New York, NY 10032, USA.

Current Opinion in Clinical Nutrition and Metabolic Care
|December 17, 2009
PubMed
Summary

Ectopic lipid accumulation in the heart, or lipotoxic cardiomyopathy, is a growing concern linked to obesity and type 2 diabetes. Research in humans and animals is crucial for understanding and treating this condition.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
07:10

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts

Published on: May 16, 2021

Related Experiment Videos

Last Updated: Jun 17, 2026

Slicing and Culturing Pig Hearts under Physiological Conditions
07:54

Slicing and Culturing Pig Hearts under Physiological Conditions

Published on: March 20, 2020

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
07:10

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts

Published on: May 16, 2021

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Ectopic lipid accumulation in the heart is an emerging health issue, exacerbated by rising rates of type 2 diabetes and obesity.
  • Cardiac lipotoxicity, a consequence of abnormal lipid deposition, significantly impacts heart function and overall health.

Purpose of the Study:

  • To review current human and animal research on cardiac lipotoxicity.
  • To provide an update on the understanding of diseases associated with ectopic lipid disposition.

Main Methods:

  • Analysis of human studies correlating heart dysfunction with triglyceride content.
  • Examination of gene expression changes in human heart samples related to lipid accumulation.
  • Review of genetically modified mouse models exhibiting lipotoxic cardiomyopathies.

Main Results:

  • Human studies establish a clear link between elevated triglyceride levels and cardiac dysfunction.
  • Gene expression analysis in human heart tissue reveals molecular alterations due to lipid accumulation.
  • Animal models demonstrate the development of lipotoxic cardiomyopathies, aiding in the study of therapeutic interventions.

Conclusions:

  • Human studies are vital for confirming metabolic changes in lipotoxic cardiomyopathy.
  • Animal studies are expected to guide the development of effective treatment strategies for cardiac lipotoxicity.